2019年模型中恶性肿瘤治疗的诊断相关分组和支付

D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Y. Seryapina, Y. Ledovskikh
{"title":"2019年模型中恶性肿瘤治疗的诊断相关分组和支付","authors":"D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Y. Seryapina, Y. Ledovskikh","doi":"10.17749/2070-4909.2019.12.3.169-177","DOIUrl":null,"url":null,"abstract":"The article addresses the model of diagnosis-related groups (DRG) updated according to the new tariffs in the compulsory medical insurance. Especially emphasized are changes made in the DRG model of 2019, which resulted from the previous work on the development and revision of the clinical recommendations in oncology, as well as the regulation changes in the healthcare system. In addition, the article describes the functioning of the DRG model in 2018 and the payment for cancer care and also provides examples from the practice of chemotherapy. The modifications made in the 2019 model are carefully discussed in terms of: expanding the list of oncological diagnoses, creating and characterizing new DRG groups, updating the coding system and the structure of reference books, changing the Guidebook recommendations and the Instruction related to oncological groups. Clarifications are given regarding frequently asked questions on payments for the medical care in oncology within the current DRG model.  ","PeriodicalId":201824,"journal":{"name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019\",\"authors\":\"D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Y. Seryapina, Y. Ledovskikh\",\"doi\":\"10.17749/2070-4909.2019.12.3.169-177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article addresses the model of diagnosis-related groups (DRG) updated according to the new tariffs in the compulsory medical insurance. Especially emphasized are changes made in the DRG model of 2019, which resulted from the previous work on the development and revision of the clinical recommendations in oncology, as well as the regulation changes in the healthcare system. In addition, the article describes the functioning of the DRG model in 2018 and the payment for cancer care and also provides examples from the practice of chemotherapy. The modifications made in the 2019 model are carefully discussed in terms of: expanding the list of oncological diagnoses, creating and characterizing new DRG groups, updating the coding system and the structure of reference books, changing the Guidebook recommendations and the Instruction related to oncological groups. Clarifications are given regarding frequently asked questions on payments for the medical care in oncology within the current DRG model.  \",\"PeriodicalId\":201824,\"journal\":{\"name\":\"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17749/2070-4909.2019.12.3.169-177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17749/2070-4909.2019.12.3.169-177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文讨论了根据强制医疗保险新费率更新的诊断相关组(DRG)模型。特别强调的是2019年DRG模型的变化,这是由于之前在肿瘤学临床建议的制定和修订方面的工作,以及医疗保健系统的监管变化。此外,文章还描述了DRG模型在2018年的运行情况和癌症治疗的支付情况,并提供了化疗实践的例子。对2019年模型所做的修改进行了仔细的讨论:扩大肿瘤诊断列表,创建和表征新的DRG组,更新编码系统和参考书结构,更改指南建议和与肿瘤组相关的指令。澄清了关于当前DRG模式下肿瘤学医疗保健支付的常见问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019
The article addresses the model of diagnosis-related groups (DRG) updated according to the new tariffs in the compulsory medical insurance. Especially emphasized are changes made in the DRG model of 2019, which resulted from the previous work on the development and revision of the clinical recommendations in oncology, as well as the regulation changes in the healthcare system. In addition, the article describes the functioning of the DRG model in 2018 and the payment for cancer care and also provides examples from the practice of chemotherapy. The modifications made in the 2019 model are carefully discussed in terms of: expanding the list of oncological diagnoses, creating and characterizing new DRG groups, updating the coding system and the structure of reference books, changing the Guidebook recommendations and the Instruction related to oncological groups. Clarifications are given regarding frequently asked questions on payments for the medical care in oncology within the current DRG model.  
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信